Ryan Specialty (NYSE:RYAN) Lowered to “Strong Sell” Rating by Zacks Research

Ryan Specialty (NYSE:RYAN) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Tuesday,Zacks.com reports.

Several other research analysts also recently commented on RYAN. JPMorgan Chase & Co. dropped their price target on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating on the stock in a research report on Wednesday, January 7th. TD Cowen restated a “buy” rating on shares of Ryan Specialty in a research note on Wednesday, November 26th. Wells Fargo & Company cut their target price on shares of Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Cantor Fitzgerald reduced their price target on shares of Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating for the company in a report on Tuesday, February 17th. Finally, Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $65.00 to $55.00 and set an “outperform” rating on the stock in a research report on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $57.47.

Ryan Specialty Stock Performance

NYSE:RYAN opened at $38.01 on Tuesday. Ryan Specialty has a 1 year low of $37.29 and a 1 year high of $77.16. The firm’s fifty day simple moving average is $47.95 and its 200 day simple moving average is $52.90. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. The firm has a market capitalization of $10.04 billion, a PE ratio of 90.50, a PEG ratio of 1.02 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million for the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The firm’s revenue was up 13.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.45 EPS. On average, sell-side analysts anticipate that Ryan Specialty will post 2.29 EPS for the current year.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the purchase, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. The trade was a 6.33% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Timothy William Turner sold 129,570 shares of Ryan Specialty stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $53.61, for a total value of $6,946,247.70. Following the sale, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. The trade was a 91.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 52.21% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of RYAN. Sumitomo Mitsui Trust Group Inc. increased its position in Ryan Specialty by 2.5% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,387,108 shares of the company’s stock worth $78,177,000 after purchasing an additional 33,588 shares during the period. Cooper Investors PTY Ltd. boosted its stake in shares of Ryan Specialty by 33.9% in the 3rd quarter. Cooper Investors PTY Ltd. now owns 505,374 shares of the company’s stock valued at $28,483,000 after purchasing an additional 127,892 shares during the last quarter. Marshall Wace LLP grew its position in shares of Ryan Specialty by 142.1% during the 2nd quarter. Marshall Wace LLP now owns 380,116 shares of the company’s stock worth $25,844,000 after buying an additional 223,124 shares during the period. Waters Parkerson & CO. LLC grew its position in shares of Ryan Specialty by 4.3% during the 3rd quarter. Waters Parkerson & CO. LLC now owns 508,120 shares of the company’s stock worth $28,638,000 after buying an additional 20,920 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Ryan Specialty by 56.0% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 68,671 shares of the company’s stock worth $3,870,000 after buying an additional 24,656 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.